1. Home
  2. PLRX vs MPB Comparison

PLRX vs MPB Comparison

Compare PLRX & MPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLRX
  • MPB
  • Stock Information
  • Founded
  • PLRX 2015
  • MPB 1868
  • Country
  • PLRX United States
  • MPB United States
  • Employees
  • PLRX N/A
  • MPB N/A
  • Industry
  • PLRX Biotechnology: Pharmaceutical Preparations
  • MPB Major Banks
  • Sector
  • PLRX Health Care
  • MPB Finance
  • Exchange
  • PLRX Nasdaq
  • MPB Nasdaq
  • Market Cap
  • PLRX 77.3M
  • MPB 641.4M
  • IPO Year
  • PLRX 2020
  • MPB N/A
  • Fundamental
  • Price
  • PLRX $1.44
  • MPB $29.25
  • Analyst Decision
  • PLRX Hold
  • MPB Buy
  • Analyst Count
  • PLRX 10
  • MPB 2
  • Target Price
  • PLRX $9.79
  • MPB $36.00
  • AVG Volume (30 Days)
  • PLRX 1.6M
  • MPB 109.9K
  • Earning Date
  • PLRX 08-06-2025
  • MPB 07-23-2025
  • Dividend Yield
  • PLRX N/A
  • MPB 2.74%
  • EPS Growth
  • PLRX N/A
  • MPB 23.94
  • EPS
  • PLRX N/A
  • MPB 2.88
  • Revenue
  • PLRX N/A
  • MPB $181,865,000.00
  • Revenue This Year
  • PLRX N/A
  • MPB $24.31
  • Revenue Next Year
  • PLRX N/A
  • MPB $13.74
  • P/E Ratio
  • PLRX N/A
  • MPB $10.13
  • Revenue Growth
  • PLRX N/A
  • MPB 9.21
  • 52 Week Low
  • PLRX $1.10
  • MPB $22.50
  • 52 Week High
  • PLRX $16.10
  • MPB $33.87
  • Technical
  • Relative Strength Index (RSI)
  • PLRX 55.31
  • MPB 61.31
  • Support Level
  • PLRX $1.13
  • MPB $29.03
  • Resistance Level
  • PLRX $1.27
  • MPB $30.00
  • Average True Range (ATR)
  • PLRX 0.11
  • MPB 0.63
  • MACD
  • PLRX 0.03
  • MPB 0.14
  • Stochastic Oscillator
  • PLRX 93.33
  • MPB 68.11

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

About MPB Mid Penn Bancorp

Mid Penn Bancorp Inc operates in the financial services domain. It conducts commercial banking and trust business in the United States. Its range of services comprises mortgage and home equity loans, secured and unsecured consists and consumer loans, lines of credit, construction financing, farm loans, community development, local government loans, and various types of time and demand deposits.

Share on Social Networks: